REGENERON PHARMACEUTICALS (REGN)

US75886F1075 - Common Stock

738  -6.5 (-0.87%)

After market: 738 0 (0%)

Buy % Consensus

78

ChartMill assigns a Buy % Consensus number of 78% to REGN. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 1108.02. This target is 50.14% above the current price.
REGN was analyzed by 34 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about REGN.
In the previous month the buy percentage consensus was at a similar level.
REGN was analyzed by 34 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 738.00808.001,148.521,108.021,291.50 - 9.49% 55.63% 50.14% 75.00%
Up and Down Grades
Date Firm Action Rating
2024-11-15 Wolfe Research Initiate Outperform
2024-11-14 Citigroup Initiate Neutral
2024-11-06 Oppenheimer Maintains Outperform -> Outperform
2024-11-01 BMO Capital Maintains Outperform -> Outperform
2024-11-01 RBC Capital Maintains Outperform -> Outperform
2024-11-01 Barclays Maintains Overweight -> Overweight
2024-11-01 Truist Securities Maintains Buy -> Buy
2024-11-01 Morgan Stanley Maintains Overweight -> Overweight
2024-11-01 Piper Sandler Maintains Overweight -> Overweight
2024-10-25 RBC Capital Reiterate Outperform -> Outperform
2024-10-24 Evercore ISI Group Maintains Outperform -> Outperform
2024-10-24 JP Morgan Maintains Overweight -> Overweight
2024-10-23 Cantor Fitzgerald Reiterate Neutral -> Neutral
2024-10-23 Barclays Maintains Overweight -> Overweight
2024-10-22 RBC Capital Reiterate Outperform -> Outperform
2024-10-22 Wells Fargo Maintains Overweight -> Overweight
2024-10-16 Truist Securities Maintains Buy -> Buy
2024-10-04 RBC Capital Maintains Outperform -> Outperform
2024-09-24 Leerink Partners Downgrade Outperform -> Market Perform
2024-09-24 BMO Capital Reiterate Outperform -> Outperform
2024-09-24 RBC Capital Maintains Outperform -> Outperform
2024-09-24 Truist Securities Reiterate Buy -> Buy
2024-09-23 Wells Fargo Reiterate Overweight -> Overweight
2024-09-17 RBC Capital Reiterate Outperform -> Outperform
2024-09-16 Cantor Fitzgerald Reiterate Neutral -> Neutral
2024-09-09 Cantor Fitzgerald Reiterate Neutral -> Neutral
2024-09-09 RBC Capital Maintains Outperform -> Outperform
2024-09-05 RBC Capital Reiterate Outperform -> Outperform
2024-08-23 Piper Sandler Maintains Overweight -> Overweight
2024-08-02 Guggenheim Maintains Buy -> Buy